Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population;Utilidad de la herramienta FRAX en el tratamiento de la osteoporosis en población femenina española

Medicina Clinica

Volumn 136, Issue 14, 2011, Pages 613-619

  Azagra Ledesma, Rafael ^a,b,e   Prieto Alhambra, Daniel ^a,c   Encabo Duró, Gloria ^a,e   Casado Burgos, Enrique ^d,e   Aguyé Batista, Amada ^c,e   Díez Pérez, Adolfo ^a   Fernández Hermida, Yolanda ^e   Fuentes, Manuela ^e   Gené, Emili ^e   Gisbert, Ma Carme ^e   Güell, Silvia ^e   Iglesias, Milagros ^e   López Expósito, Francesc ^e   Martín Sánchez, Juan Carlos ^e   Ortiz, Sergi ^e   Puchol, Nuria ^e   Puente, Ana ^e   Roca, Genís ^e   Sabaté, Victòria ^e   Sancho, Maria Pilar ^e   Solà, Silvia ^e   Vilaseca, Anna ^e   Zwart, Marta ^e   more..

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^c INSTITUT CATALÀ DE LA SALUT   (Spain)

^d PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

^e NONE

Author keywords

DXA scan; FRAX tool; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC VALUE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FEMUR NECK OSTEOPOROSIS; FRACTURE; FRACTURE RISK ASSESSMENT TOOL; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PATIENT REFERRAL; PRACTICE GUIDELINE; PREDICTIVE VALUE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SPAIN; VALIDATION STUDY;

EID: 79955958365     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.09.043     Document Type: Article

References (30)

1. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985;7:178-208. (Pubitemid 15236006)
2. Kanis JA, Johnell O. Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int. 2005;16:229-38. (Pubitemid 40379422)
3. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton III LJ, Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;42:467-75.
4. Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C, et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int. 2002;13:527-36. (Pubitemid 34790624)
5. Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, et al. Longterm risk of osteoporotic fracture in Malmo. Osteoporos Int. 2000;11:669-74.
6. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey EV. FRAX™ and the assessment of fracture probability in men and women in the UK. Osteoporos Int. 2008;19:385-97.
7. Borgström F, Johnell O, Kanis JA, Jönsson B, Rehnberg C. At what hip fracture thresholds for the treatment of osteoporosis. Osteoporos Int. 2006;17:1459-71.
8. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008;19:399-428.
9. Kanis J, on behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary health-care level. Technical Report. Reino Unido: WHO Collaborating Centre, University of Sheffield; 2008. Versión en español disponible en: www.shef.ac.uk/FRAX/tool-SP.jsp? locationValue=4
10. Kanis JA, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women - what is the current message for clinical practice? Pol Arch Med Wewn. 2008;118:538-40.
11. O'Neill TW, Marsden D, Matthis C, Raspe H, Silman AJ. Survey response rates: national and regional differences in a European multicentre study of vertebral osteoporosis. J Epidemiol Community Health. 1995;49:87-93.
12. Alonso-Coello P, Marzo-Castillejo M, Ló pez A, Isasi C, Landa J, Nishishinya B. Guía de prá ctica clínica sobre menopausia: evaluación del riesgo de fractura y cribado de la osteoporosis (parte 2). Aten Primaria. 2005;36:9-15.
13. Ferrer A, Estrada MD, Borràs A, Espallargues M. Guía para la indicación de la densitometría ó sea en la valoración del riesgo de fractura y en el control evolutivo de la osteoporosis. Med Clin (Barc). 2009;132:428-36.
14. Gonzá lez J, Guañabens N, Gómez C, del Río L, Muñoz M, Delgado M, et al., en representación de la Sociedad Española de Investigación Ó sea y del Metabolismo. Guías de prá ctica Clínica en la osteoporosis postmenopá usica, glucocorticoidea y del varó n. Rev Clin Esp. 2008;208 Suppl 1:1-24.
15. Arana-Arri E, Gutié rrez-Ibarluzea I, Gutié rrez ML, Ortueta P, Giménez AB, Sánchez AM, et al. Aná lisis comparativo frente a la evidencia del manejo de la osteoporosis en una comarca de atención primaria. Aten Primaria. 2008;40:549-54.
16. Roig D, Valero C, en representación del Grupo de estudio de criterios de derivación a densitometría. Proporción de individuos con criterios de indicacio ́n de densitometría ó sea y frecuencia de los factores de riesgo de baja masa ó sea en consultas de atención primaria. Aten Primaria. 2006;38:435-42.
17. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A, et al. Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int. 2008;19:1395-408.
18. Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, et al. Osteoporosis. Clinical guideline for prevention and treatment. National Osteoporosis Guideline Group; 2009. Disponible en: www.shef.ac.uk/NOGG/
19. Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, et al., on behalf of the National Osteoporosis Guideline Group (NOGG). Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas. 2009;62:105-8.
20. Kanis JA, Johansson H, Oden A, Dawson-Hughes B, Melton 3rd LJ, McCloskey EV. The effects of a FRAX revision for the USA. Osteoporos Int. 2010;21:35-40.
21. Fujiwara S, Nakamura T, Orimo H, Hosoi T, Gorai I, Oden A, et al. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™). Osteoporos Int. 2008;19:429-35.
22. Lippuner K, Johansson H, Kanis JA, Rizzoli R. Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int. 2009;20:1131-40.
23. Lippuner K, Johansson H, Kanis JA, Rizzoli R. FRAX assessment of osteoporotic fracture probability in Switzerland. Osteoporos Int. 2010;21:381-9.
24. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series, vol. 843. Ginebra: WHO;1994.
25. Roig Vilaseca D, Gómez Vaquero C, Hoces Otero C, Nolla JM. Registro de fractura calculado con el índice FRAX en pacientes con osteoporosis tratados y no tratados. Med Clin (Barc). 2009;134:189-93.
26. Berry SD, Kiel DP, Donaldson MG, Cummings SR, Kanis JA, Johansson H, et al. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study. Osteoporos Int. 2010;21:53-60.
27. Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, Manitoba Bone Density Program. Independent clinical validation of a Canadian FRAX© tool: Fracture prediction and model calibration. J Bone Miner Res. 2010;25:2350-8.
28. Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001;12:519-28. (Pubitemid 32777427)
29. Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ. 2009;339:b4229.
30. Vila J, Marín F, González-Macías J, Martín D, Tojeiro S, Díez-Pérez A, en representación de los investigadores del proyecto ECOSAP. Validación de un algoritmo para calcular el riesgo absoluto de fractura no vertebral por fragilidad en una cohorte de mujeres postmenopáusicas. Med Clin (Barc). 2009;133:501-5.